Defining the Debate in Soft Tissue Robotics

 To level-set the discussion, Mullings began by asking the panelists to define what “open” and “closed” mean in the context of soft tissue robotics. Greg Roche, CEO of Distalmotion, put it simply: “Choice is the difference between open and closed. When you close something down, you limit the offering in the long term.” Roche argued that open systems allow surgeons and hospitals to pick best-in-class technologies across the surgical stack, building a custom ecosystem instead of being locked into a single vendor. Scott Huennekens, former CEO of Verb Surgical and longtime digital surgery leader, offered a broader systems view. “I never even liked the term ‘robotic surgery.’ I always preferred ‘digital surgery,’” he said. “It’s not just about the robot. It’s about instruments, connectivity, data, analytics, and precision guidance, all working together.” For more information visit here: https://anyflip.com/ybicl/nomu/basic

Comments

Post a Comment

Popular posts from this blog

LSI USA ‘26 FAQs

General FAQs 01 When and where will LSI USA ’26 be held? LSI USA ’26 takes place March 16–20, 2026, at the Waldorf Astoria Monarch Beach Resort in Dana Point, California. Secure your accommodations early as exclusive hotel rates are available while supplies last. Book hotel here 02 Who attends LSI USA ‘26? 1800+ medtech and healthtech founders, startups, investors, strategics, and service providers attend LSI events each year. Registration FAQs 01 Where can I register for LSI USA ‘26? Register for LSI USA ’26 here . You can also apply to present at LSI USA ’26 here . 02 What does my LSI USA ’26 registration include? Registration includes access to all days of the event (March 16–20), all sessions, meals, networking receptions, and the partnering platform. 03 Will meals be provided during the event? Yes. Breakfast, lunch, and dinner will be served on March 17, March 18, and March 19, with an additional dinner served on March 16 during the Welcome Reception. 04 Can I register a group of ...
Read more

Big Tech and Big Pharma: How Medtech Can Bridge the Gap

As technologies evolve and  healthcare innovation  accelerates, the traditional boundaries separating medtech, big tech, and big pharma are increasingly blurry — but the cultural and strategic gaps between them remain. At LSI USA ’25, panelists Juan-Pablo Mas (Action Potential Venture Capital), Nishant Doctor (Surf Therapeutics), and Jordi Parramon (Nexus NeuroTech Ventures) joined moderator Katie Elias to examine how medtech can better align with  big tech and big pharma  to drive innovation forward. The conversation centered on key differences in development strategy, investor expectations, and business timelines — critical challenges that arise when building partnerships or raising capital across sectors. As medtech companies seek broader platforms and more ambitious outcomes, understanding and navigating these differences becomes essential for effective cross-sector collaboration and long-term success. Understanding the Evidence Gap A major area of divergence bet...
Read more

LSI USA ‘26 Registration FAQs

01 Where can I register for LSI USA ‘26? Register for LSI USA ’26 here . You can also apply to present at LSI USA ’26 here . 02 What does my LSI USA ’26 registration include? Registration includes access to all days of the event (March 16–20), all sessions, meals, networking receptions, and the partnering platform. 03 Will meals be provided during the event? Yes. Breakfast, lunch, and dinner will be served on March 17, March 18, and March 19, with an additional dinner served on March 16 during the Welcome Reception. 04 Can I register a group of people for LSI USA ‘26? Yes. Please contact kelly@ls-intel.com for more details. 05 Can I get a discount for registering for multiple LSI events? Please contact kelly@ls-intel.com for more details. 06 I’m a very early-stage startup. Is it too soon for me to attend or present at LSI USA ‘26? Not at all. LSI features startups ranging from pre-seed to Series D and beyond, alongside early-stage investors, growth-stage VCs, and strategics. It’s never...
Read more